|
Description
Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), Calgary has been granted U.S. Patent 7,223,585 entitled "Viral Purification Methods." The claims cover the production and purification of viruses including reovirus.
"This patent expands our intellectual property portfolio well beyond that of reovirus," said Dr. Matt Coffey, Chief Scientific Officer of... |
Looking for additional articles?
Click here
to search our database of over 3 million articles.
|
